Sudipta Baroi

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Postdoctoral Research Fellow

UAMS

Also affiliated: Harvard University (2023–2024); University of Dhaka (2020); University of Toledo (2018–2026)

9 h-index 17 pubs 240 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Sudipta Baroi's research focuses on the role of nuclear receptors, particularly PPARs (peroxisome proliferator-activated receptors), in bone health and systemic energy metabolism. His work investigates how these receptors, specifically PPARG in osteocytes, influence bone mass, marrow adiposity, and sclerostin expression. Baroi has also explored the contribution of PPAR-alpha to bone maintenance and systemic energy metabolism. His publications address the impact of diabetes on fracture healing and the potential of targeting marrow fat for treating bone diseases. He has also investigated the function of Sfrp4 in maintaining the stem cell niche and the regulation of bone mass and skeletal stem cell bioenergetics by carboxypeptidase E. Baroi's research utilizes animal models, including mice and rats, and considers human relevance in his studies.

Metrics

h-index: 9
Publications: 17
Citations: 240

Positions

Postdoctoral Research Fellow 2024–present

University of Arkansas for Medical Sciences Department of Physiology and Cell Biology ORCID
Research Fellow 2022–2024

Harvard University Division of Bone and Mineral Research, Department of Oral Medicine, Infection and Immunity ORCID
Research Assistant 2016–2022

University of Toledo Department of Orthopedic Surgery ORCID

Selected Publications

Osteocytes secrete adiponectin and display adipocyte-like phenotype under control of PPARG nuclear receptor (2026)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex

View all publications on OpenAlex →